Project 1600

Project 1600 is a privately held U.S. consumer wellness company that operates the DML CBD / DML Pure online business and sells hemp-derived cannabidiol products under brands including Miracle Me. The company appears to have been founded in 2018 and launched its CBD business in 2019, focusing on direct-to-consumer tinctures and related wellness products marketed nationally in the United States. It is not a traditional biotech or pharmaceutical developer and there is no evidence of a drug-development pipeline, clinical-stage therapeutics, or proprietary therapeutic platform. The company received FDA and FTC warning letters in June 2020 related to unsupported COVID-19 treatment and prevention claims for its CBD products. Based on currently available public information, Project 1600 is best characterized as an active commercial cannabinoid wellness company rather than a life sciences R&D company.